Karin Frank‐Raue

7.5k total citations · 1 hit paper
106 papers, 4.7k citations indexed

About

Karin Frank‐Raue is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Karin Frank‐Raue has authored 106 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Karin Frank‐Raue's work include Thyroid Cancer Diagnosis and Treatment (67 papers), Neuroendocrine Tumor Research Advances (42 papers) and Thyroid and Parathyroid Surgery (22 papers). Karin Frank‐Raue is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (67 papers), Neuroendocrine Tumor Research Advances (42 papers) and Thyroid and Parathyroid Surgery (22 papers). Karin Frank‐Raue collaborates with scholars based in Germany, United States and France. Karin Frank‐Raue's co-authors include Friedhelm Raue, Henning Dralle, Andreas Machens, Rossella Elisei, Steven G. Waguespack, Martin Schlumberger, M. Sara Rosenthal, L. Sylvia, Douglas B. Evans and Bruce Robinson and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Karin Frank‐Raue

99 papers receiving 4.5k citations

Hit Papers

Revised American Thyroid Association Guidelines for the M... 2015 2026 2018 2022 2015 400 800 1.2k

Peers

Karin Frank‐Raue
Terry C. Lairmore United States
Naifa L. Busaidy United States
Tobias Carling United States
C Proye France
Terry C. Lairmore United States
Karin Frank‐Raue
Citations per year, relative to Karin Frank‐Raue Karin Frank‐Raue (= 1×) peers Terry C. Lairmore

Countries citing papers authored by Karin Frank‐Raue

Since Specialization
Citations

This map shows the geographic impact of Karin Frank‐Raue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Frank‐Raue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Frank‐Raue more than expected).

Fields of papers citing papers by Karin Frank‐Raue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Frank‐Raue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Frank‐Raue. The network helps show where Karin Frank‐Raue may publish in the future.

Co-authorship network of co-authors of Karin Frank‐Raue

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Frank‐Raue. A scholar is included among the top collaborators of Karin Frank‐Raue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Frank‐Raue. Karin Frank‐Raue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raue, Friedhelm & Karin Frank‐Raue. (2025). What Is New in Diagnostics and Management of Medullary Thyroid Carcinoma. Recent results in cancer research. 223. 1–8.
2.
Frank‐Raue, Karin & Friedhelm Raue. (2023). Thyroid dysfunction in peri- and postmenopausal women—cumulative risks. Deutsches Ärzteblatt international. 120(18). 311–316. 4 indexed citations
3.
Wendler, Julia, Karin Frank‐Raue, Michael C. Kreißl, et al.. (2020). Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology. The Journal of Clinical Endocrinology & Metabolism. 105(6). e2239–e2246. 10 indexed citations
4.
Frank‐Raue, Karin, Friedhelm Raue, Eva Hoster, et al.. (2020). Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer. Thyroid. 31(3). 459–469. 46 indexed citations
5.
Wells, Samuel A., L. Sylvia, Henning Dralle, et al.. (2015). Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 25(6). 567–610. 1443 indexed citations breakdown →
6.
Raue, Friedhelm & Karin Frank‐Raue. (2015). Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma. Recent results in cancer research. 204. 61–90. 40 indexed citations
7.
Machens, Andreas, Kerstin Lorenz, Carsten Sekulla, et al.. (2012). Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium. European Journal of Endocrinology. 168(3). 307–314. 63 indexed citations
8.
Frank‐Raue, Karin, Christine Haag, Egbert Schulze, et al.. (2011). CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. European Journal of Endocrinology. 165(3). 477–483. 28 indexed citations
9.
Haag, Christine, Helmuth‐Günther Dörr, Dirk Schnabel, et al.. (2010). Novel Activating Mutations of the Calcium-Sensing Receptor: The Calcilytic NPS-2143 Mitigates Excessive Signal Transduction of Mutant Receptors. The Journal of Clinical Endocrinology & Metabolism. 95(10). E229–E233. 44 indexed citations
10.
Raue, Friedhelm, Christine Haag, E Schulze, & Karin Frank‐Raue. (2009). Familiäre hypokalziurische Hyperkalziämie - aktuelle Diagnostik und Therapie. Journal für Kardiologie (Krause & Pachernegg GmbH). 16(2). 80–83. 1 indexed citations
11.
Frank‐Raue, Karin, Wolfgang Höppner, H. J. Buhr, Ch. Herfarth, & Friedhelm Raue. (2009). Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy. Experimental and Clinical Endocrinology & Diabetes. 105(S 04). 76–78. 1 indexed citations
12.
Frank‐Raue, Karin, et al.. (2009). Long-term outcome of “prophylactic therapy” for familial medullary thyroid cancer. Surgery. 146(5). 906–912. 5 indexed citations
13.
Frank‐Raue, Karin & Friedhelm Raue. (2009). Multiple endocrine neoplasia type 2 (MEN 2). European Journal of Cancer. 45. 267–273. 10 indexed citations
14.
Frank‐Raue, Karin, F. Raue, SIGRUN KORTH-SCHÜTZ, P. Vecsei, & Regina G. Ziegler. (2008). Klinik und Diagnostik bei Männern mit leichtem 3β-Hydroxysteroiddehydrogenase-Mangel. DMW - Deutsche Medizinische Wochenschrift. 114(9). 331–334.
15.
Frank‐Raue, Karin, M. Fabel, Stefan Delorme, Uwe Haberkorn, & Friedhelm Raue. (2007). Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma. European Journal of Endocrinology. 157(2). 215–220. 72 indexed citations
16.
Machens, Andreas, Ludwig Schaaf, Wölfram Karges, et al.. (2007). Age‐related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clinical Endocrinology. 67(4). 613–622. 114 indexed citations
17.
Weber, Theresia, Tobias Schilling, Karin Frank‐Raue, et al.. (2001). Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery. 130(6). 1044–1049. 103 indexed citations
18.
Hotz, Holger, Norbert Runkel, Karin Frank‐Raue, Friedhelm Raue, & H. J. Buhr. (1998). Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?. Langenbecks Archiv für Chirurgie. 383(2). 170–170. 12 indexed citations
19.
Frank‐Raue, Karin, et al.. (1995). Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clinical Endocrinology. 42(1). 31–37. 43 indexed citations
20.
McBride, Martin, Alan J. Russell, Keith Vass, et al.. (1995). The human 3β-hydroxysteroid dehydrogenase (3β-HSD) gene cluster on chromosome 1p13 contains a presumptive pseudogene; 3β-HSD and CYP17 do not segregate with dominantly inherited hirsutism. Journal of Molecular Endocrinology. 15(2). 167–176. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026